SIRT1 and Hepatic steatosis: Then, we performed an in vitro study to explore the hypothesis that E2 treatment could protect mitochondrial function, reduce lipid oxidation, and prevent hepatic steatosis by upregulating the ERα/SIRT1/PGC-1α pathway.